1,2,3,4-tetrahydroquinoline-based selective human neuronal nitric oxide synthase (nNOS) inhibitors: lead optimization studies resulting in the identification of N-(1-(2-(methylamino)ethyl)-1,2,3,4-tetrahydroquinolin-6-yl)thiophene-2-carboximidamide as a preclinical development candidate

Journal of Medicinal Chemistry
Jailall RamnauthFrank Porreca

Abstract

Numerous studies have shown that selective nNOS inhibitors could be therapeutic in many neurological disorders. Previously, we reported a series of 1,2,3,4-tetrahydroquinoline-based potent and selective nNOS inhibitors, highlighted by 1 ( J. Med. Chem. 2011 , 54 , 5562 - 5575 ). Despite showing activity in two rodent pain models, 1 suffered from low oral bioavailability (18%) and moderate hERG channel inhibition (IC(50) = 4.7 μM). To optimize the properties of 1, we synthesized a small focused library containing various alkylamino groups on the 1-position of the 1,2,3,4-tetrahydroquinoline scaffold. The compounds were triaged based on their activity in the NOS and hERG manual patch clamp assays and their calculated physicochemical parameters. From these studies, we identified 47 as a potent and selective nNOS inhibitor with improved oral bioavailability (60%) and no hERG channel inhibition (IC(50) > 30 μM). Furthermore, 47 was efficacious in the Chung model of neuropathic pain and has an excellent safety profile, making it a promising preclinical development candidate.

References

Dec 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·L J IgnarroG Chaudhuri
Jan 1, 1997·Annual Review of Pharmacology and Toxicology·D J Stuehr
Mar 29, 2001·Journal of Pharmacological and Toxicological Methods·C A Lipinski
Dec 4, 2002·Nature Reviews. Drug Discovery·Patrick Vallance, James Leiper
Mar 21, 2003·Journal of Medicinal Chemistry·Mark C WenlockPaul D Leeson
May 31, 2003·Nature Reviews. Drug Discovery·Bernard Fermini, Anthony A Fossa
Sep 19, 2003·European Journal of Clinical Pharmacology·Lisbeth Hjorth LassenJes Olesen
Aug 17, 2005·Current Topics in Medicinal Chemistry·Erik P ErdalRichard B Silverman
Nov 10, 2006·The New England Journal of Medicine·Ferid Murad
Jan 24, 2007·Bioorganic & Medicinal Chemistry Letters·Michael J Waring, Craig Johnstone
Feb 24, 2007·Bioorganic & Medicinal Chemistry Letters·Joanne PatmanJohn S Andrews
Sep 21, 2007·Nature Reviews. Neuroscience·Vittorio CalabreseAnna Maria Giuffrida Stella
Jan 28, 2009·Cephalalgia : an International Journal of Headache·A KarlovasitouS Baloyannis
Aug 14, 2009·Cephalalgia : an International Journal of Headache·H-J GruberM Truschnig-Wilders
Aug 26, 2009·Acta Anaesthesiologica Scandinavica·A Miclescu, T Gordh
Aug 5, 2011·Bioorganic & Medicinal Chemistry Letters·Paul RentonJohn Andrews
Aug 10, 2011·Bioorganic & Medicinal Chemistry Letters·Shawn MaddafordFrank Porreca
Apr 1, 2007·Expert Opinion on Drug Discovery·Cele Abad-Zapatero

❮ Previous
Next ❯

Citations

Jul 30, 2014·Proceedings of the National Academy of Sciences of the United States of America·Julius SemenasJenny L Persson
Mar 5, 2013·Journal of Medicinal Chemistry·He HuangRichard B Silverman
Feb 20, 2014·Chemical Society Reviews·Paramita MukherjeeRichard B Silverman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.